Pharmacotherapy

Keyphrases

Publications

volume 44, number 3, 2024

Tyler Chanas, Gabrielle Gibson, Elizabeth Langenstroer, David J Herrmann, Thomas W Carver, Kaitlin M Alexander, Sai Ho Jason Chui, Lisa Rein, Michael Ha, Kaylee M Maynard, Kristen Bamberg, Mary M O'Keefe, Marisa O'Brien, Mariela Cardona Gonzalez, Brandon Hobbs, Mehrnaz Pajoumand, William J Peppard
Multicenter study evaluating target attainment of anti-Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients. Pharmacotherapy 44 (3) (2024)
Kevin Lonabaugh, Galvin Li, Rhonda List, Reyna Huang, Amber James, Andrew Barros, Lindsay Somerville, Dana Albon
Real world study on elexacaftor-tezacaftor-ivacaftor impact on cholesterol levels in adults with cystic fibrosis. Pharmacotherapy 44 (3) (2024)
Hala Halawi, Jesse E Harris, Ahmad Goodarzi, Simon Yau, Jihad G Youssef, Mena M Botros, Howard J Huang
Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series. Pharmacotherapy 44 (3) (2024)
Tyler Chanas, Gabrielle Gibson, Elizabeth Langenstroer, David J Herrmann, Thomas W Carver, Kaitlin M Alexander, Sai Ho Jason Chui, Lisa Rein, Michael Ha, Kaylee M Maynard, Kristen Bamberg, Mary M O'Keefe, Marisa O'Brien, Mariela Cardona Gonzalez, Brandon Hobbs, Mehrnaz Pajoumand, William J Peppard
Multicenter study evaluating target attainment of anti-Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients. Pharmacotherapy 44 (3) (2024)

volume 44, number 4, 2024

Hope H Brandon, David S Burgess, Katie L Wallace, Elizabeth J Beckman, Katherine Olney
Vancomycin AUC 0-24 estimation using first-order pharmacokinetic methods in pediatric patients. Pharmacotherapy 44 (4) (2024)
Elmar R Alizadeh, Thierry Dervieux, Severine Vermeire, Marla Dubinsky, Geert D'Haens, David Laharie, Andrew Shim, Byron P Vaughn
Simulated cost-effectiveness of a novel precision-guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy. Pharmacotherapy 44 (4) (2024)
Kathryn Sine, Thomas Lavoie, Aisling R Caffrey, Vrishali V Lopes, David Dosa, Kerry L LaPlante, Haley J Appaneal
Exploring variations in recommended first-choice therapy for complicated urinary tract infections in males: Insights from outpatient settings across age, race, and ethnicity. Pharmacotherapy 44 (4) (2024)
Melissa N W Jackson, Wenjing Wei, Norman S Mang, Bonnie C Prokesch, Jessica K Ortwine
Combination eravacycline therapy for ventilator-associated pneumonia due to carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: A case series. Pharmacotherapy 44 (4) (2024)
Ellen Uppuluri, Niha Idrees, Nancy L Shapiro
Warfarin dosage in a postpartum woman while breastfeeding: A case report. Pharmacotherapy 44 (4) (2024)
Zhiheng Yu, Rong Chen, Cheng Zhao, Renwei Zhang, Tianyan Zhou, Yang-Yu Zhao
Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic-pharmacodynamic model of uterine contraction frequency. Pharmacotherapy 44 (4) (2024)
Ellen Uppuluri, Niha Idrees, Nancy L Shapiro
Warfarin dosage in a postpartum woman while breastfeeding: A case report. Pharmacotherapy 44 (4) (2024)
Kathryn Sine, Thomas Lavoie, Aisling R Caffrey, Vrishali V Lopes, David Dosa, Kerry L LaPlante, Haley J Appaneal
Exploring variations in recommended first-choice therapy for complicated urinary tract infections in males: Insights from outpatient settings across age, race, and ethnicity. Pharmacotherapy 44 (4) (2024)
Hope H Brandon, David S Burgess, Katie L Wallace, Elizabeth J Beckman, Katherine Olney
Vancomycin AUC 0-24 estimation using first-order pharmacokinetic methods in pediatric patients. Pharmacotherapy 44 (4) (2024)
Zhiheng Yu, Rong Chen, Cheng Zhao, Renwei Zhang, Tianyan Zhou, Yang-Yu Zhao
Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic-pharmacodynamic model of uterine contraction frequency. Pharmacotherapy 44 (4) (2024)
Elmar R Alizadeh, Thierry Dervieux, Severine Vermeire, Marla Dubinsky, Geert D'Haens, David Laharie, Andrew Shim, Byron P Vaughn
Simulated cost-effectiveness of a novel precision-guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy. Pharmacotherapy 44 (4) (2024)
Melissa N W Jackson, Wenjing Wei, Norman S Mang, Bonnie C Prokesch, Jessica K Ortwine
Combination eravacycline therapy for ventilator-associated pneumonia due to carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: A case series. Pharmacotherapy 44 (4) (2024)
Kathryn Sine, Thomas Lavoie, Aisling R Caffrey, Vrishali V Lopes, David Dosa, Kerry L LaPlante, Haley J Appaneal
Exploring variations in recommended first-choice therapy for complicated urinary tract infections in males: Insights from outpatient settings across age, race, and ethnicity. Pharmacotherapy 44 (4) (2024)

volume 44, number 5, 2024

C Michael White, Kimberly Snow Caroti, Youssef Bessada, Adrian V Hernández, William L Baker, Paul P Dobesh, Heleen van Haalen, Kirsty M Rhodes, Craig I Coleman
Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis. Pharmacotherapy 44 (5) (2024)
David B Cluck, Daniel B Chastain, Milena M McLaughlin, Spencer H Durham, Elias B Chahine, Caroline Derrick, Julie B Dumond, E Kelly Hester, Sarah B Jeter, Melissa D Johnson, Christin Kilcrease, Wesley D Kufel, Jeffrey Kwong, Amber F Ladak, Nimish Patel, Sarah E Pérez, Jonell B Poe, Charlotte A Bolch, Ian Thomas, Elizabeth Asiago-Reddy, William R Short
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy. Pharmacotherapy 44 (5) (2024)
Jyotirmoy Sarker, Emir Carkovic, Karolina Ptaszek, Todd A Lee
Antiviral influenza treatments and hemorrhage-related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database. Pharmacotherapy 44 (5) (2024)
C Lindsay DeVane
Expert consensus recommendations for innovative antiretroviral drugs. Pharmacotherapy 44 (5) (2024)
C Michael White, Kimberly Snow Caroti, Youssef Bessada, Adrian V Hernández, William L Baker, Paul P Dobesh, Heleen van Haalen, Kirsty M Rhodes, Craig I Coleman
Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis. Pharmacotherapy 44 (5) (2024)
David B Cluck, Daniel B Chastain, Milena M McLaughlin, Spencer H Durham, Elias B Chahine, Caroline Derrick, Julie B Dumond, E Kelly Hester, Sarah B Jeter, Melissa D Johnson, Christin Kilcrease, Wesley D Kufel, Jeffrey Kwong, Amber F Ladak, Nimish Patel, Sarah E Pérez, Jonell B Poe, Charlotte A Bolch, Ian Thomas, Elizabeth Asiago-Reddy, William R Short
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summary. Pharmacotherapy 44 (5) (2024)
David B Cluck, Daniel B Chastain, Milena M McLaughlin, Spencer H Durham, Elias B Chahine, Caroline Derrick, Julie B Dumond, E Kelly Hester, Sarah B Jeter, Melissa D Johnson, Christin Kilcrease, Wesley D Kufel, Jeffrey Kwong, Amber F Ladak, Nimish Patel, Sarah E Pérez, Jonell B Poe, Charlotte A Bolch, Ian Thomas, Elizabeth Asiago-Reddy, William R Short
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summary. Pharmacotherapy 44 (5) (2024)
Lily Price, Lisa Garrity, Sarah R Stiehl
Response to comment on "Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution". Pharmacotherapy 44 (5) (2024)
David B Cluck, Daniel B Chastain, Milena M McLaughlin, Spencer H Durham, Elias B Chahine, Caroline Derrick, Julie B Dumond, E Kelly Hester, Sarah B Jeter, Melissa D Johnson, Christin Kilcrease, Wesley D Kufel, Jeffrey Kwong, Amber F Ladak, Nimish Patel, Sarah E Pérez, Jonell B Poe, Charlotte A Bolch, Ian Thomas, Elizabeth Asiago-Reddy, William R Short
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy. Pharmacotherapy 44 (5) (2024)
Yongyi Zhang, Qiushun Zhang, Junchen Zhang
Comment on "Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution". Pharmacotherapy 44 (5) (2024)

volume 44, number 6, 2024

Benjamin A August, Pramodini B Kale-Pradhan
Management of invasive candidiasis: A focus on rezafungin, ibrexafungerp, and fosmanogepix. Pharmacotherapy 44 (6) (2024)
Benjamin A August, Pramodini B Kale-Pradhan
Management of invasive candidiasis: A focus on rezafungin, ibrexafungerp, and fosmanogepix. Pharmacotherapy 44 (6) (2024)
Hansa Mreyoud, Krysta S Walter, Elizabeth Wilpula, Jeong Mi Park
The efficacy and safety of sodium-glucose cotransporter-2 inhibitors in solid organ transplant recipients: A scoping review. Pharmacotherapy 44 (6) (2024)
Eleonora Camilleri, Mira Ghobreyal, Mettine H A Bos, Pieter H Reitsma, Felix J M Van Der Meer, Jesse Joachim Swen, Suzanne C Cannegieter, Nienke van Rein
Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case-cohort. Pharmacotherapy 44 (6) (2024)
Shawn Flanagan, Voon Ong, Thomas C Marbury, Alena Jandourek, Ronak G Gandhi, Taylor Sandison
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects. Pharmacotherapy 44 (6) (2024)
Cornelis F Vos, Wietske L Hemminga, Rob E Aarnoutse, Henricus Gerardus Ruhe
Increasing the bioavailability of oral esketamine by a single dose of cobicistat: A case study. Pharmacotherapy 44 (6) (2024)
Shawn Flanagan, Voon Ong, Thomas C Marbury, Alena Jandourek, Ronak G Gandhi, Taylor Sandison
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects. Pharmacotherapy 44 (6) (2024)
Hansa Mreyoud, Krysta S Walter, Elizabeth Wilpula, Jeong Mi Park
The efficacy and safety of sodium-glucose cotransporter-2 inhibitors in solid organ transplant recipients: A scoping review. Pharmacotherapy 44 (6) (2024)
Alexandre Duong, Ahmed El Gamal, Véronique Bilodeau, Justine Huot, Carole Delorme, Johanne Poudrette, Benoît Crevier, Amélie Marsot
Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population. Pharmacotherapy 44 (6) (2024)

volume 44, number 7, 2024

Elizabeth M Sherman, Allison Lorna Agwu, Juan Ambrosioni, Georg Martin Norbert Behrens, Carolyn Chu, Lauren F Collins, Humberto R Jimenez, David E Koren, Leslie McGorman, Nancy N Nguyen, Melanie R Nicol, Neha Sheth Pandit, Natacha Pierre, Kimberly K Scarsi, Gary F Spinner, Alice Tseng, Jeremy D Young, Melissa E Badowski
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists: An executive summary. Pharmacotherapy 44 (7) (2024)
Bradley J Haan, Samantha N Blackmon, Alex M Cobb, Heather E Cohen, Margaret T DeVier, Mary M Perez, Samuel F Winslow
Corticosteroids in critically ill patients: A narrative review. Pharmacotherapy 44 (7) (2024)
Elizabeth M Sherman, Allison Lorna Agwu, Juan Ambrosioni, Georg Martin Norbert Behrens, Carolyn Chu, Lauren F Collins, Humberto R Jimenez, David E Koren, Leslie McGorman, Nancy N Nguyen, Melanie R Nicol, Neha Sheth Pandit, Natacha Pierre, Kimberly K Scarsi, Gary F Spinner, Alice Tseng, Jeremy D Young, Melissa E Badowski
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists. Pharmacotherapy 44 (7) (2024)
Hua-Ping Fan, Yu Zhou, Mei-Li Chen, Kun-Hua Qiu, Xue Feng, Chao Zhou, Min-Li Zhu, Rong-Zhong Huang, Tian-Yang Hu
Effect of proton pump inhibitors versus histamine-2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers. Pharmacotherapy 44 (7) (2024)
Zhi-Chun Gu, Meng-Fei Dai, Qi Wei, Yi-Dan Yan, Jian-Yong Zheng, Gui-Ying Wang, Zheng-Qiang Wei, Chang-Qing Jing, Yong-Xiang Li, Dong-Bing Zhou, Mou-Bin Lin, Xian-Li He, Fan Li, Qian Liu, Shi-Liang Tu, Zhen-Jun Wang, Ang Li, Hou-Wen Lin, Hong-Wei Yao, Zhong-Tao Zhang, null null
Enhancing thromboprophylaxis after colorectal cancer surgery in China: Bridging the gap between evidence and implementation through pathway optimization. Pharmacotherapy 44 (7) (2024)
Hua-Ping Fan, Yu Zhou, Mei-Li Chen, Kun-Hua Qiu, Xue Feng, Chao Zhou, Min-Li Zhu, Rong-Zhong Huang, Tian-Yang Hu
Effect of proton pump inhibitors versus histamine-2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers. Pharmacotherapy 44 (7) (2024)
Ryosuke Ota, Atsushi Hirata, Takeo Hata, Masami Nishihara, Masashi Neo, Takahiro Katsumata
Incidence of serious infections in the working-age Japanese adult population with rheumatoid arthritis treated with tumor necrosis factor-α inhibitors and interleukin-6 inhibitors: A nationwide retrospective cohort study. Pharmacotherapy 44 (7) (2024)
Flory T Muanda, Matthew A Weir, Fatemeh Ahmadi, Eric McArthur, Jessica M Sontrop, Sheikh S Abdullah, Brad L Urquhart, Hasti Sadeghi, Richard B Kim, Amit X Garg
Thirty-day risk of digoxin toxicity among older adults co-prescribed trimethoprim-sulfamethoxazole versus amoxicillin: A population-based cohort study. Pharmacotherapy 44 (7) (2024)

volume 44, number 8, 2024

Auriene Jamison, Adham M Mohamed, Courtney Chedester, Kyle Klindworth, Majdi Hamarshi, Erik Sembroski
Lactated Ringer's versus normal saline in the management of acute diabetic ketoacidosis (RINSE-DKA). Pharmacotherapy 44 (8) (2024)
Dongjun Xu, Cheng Yang, Wei Cao, Xinyu Zhang, Shucong Yang, Xuning Shen, Jun Xu, Huijie Yu
Platelet glycoprotein IIb/IIIa antagonists in ischemic stroke patients without endovascular therapy: A meta-analysis. Pharmacotherapy 44 (8) (2024)
Qin-Jie Yang, Bi-Xiao Xiang, Mong-Hsiu Song, Chien-Yi Yang, Jun-Hao Liang, Yue-Liang Xie, Xiao-Cong Zuo
Acute kidney injury with intravenous colistin sulfate compared with polymyxin B in critically ill patients: A real-world, retrospective cohort study. Pharmacotherapy 44 (8) (2024)
Christina Koenig, Joseph L Kuti
Evolving resistance landscape in gram-negative pathogens: An update on β-lactam and β-lactam-inhibitor treatment combinations for carbapenem-resistant organisms. Pharmacotherapy 44 (8) (2024)
Shibing Tao, Shanlan Guo, Nanwei Tong
Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection. Pharmacotherapy 44 (8) (2024)
Katherine Olney, Manjunath Amit P Pai, Jenni K Thomas, Donna R Burgess, William J Olney, Rebecca A Bruning, Kamron A Griffith, Danielle V Casaus, Elizabeth Crance, James Z Porterfield, David S Burgess
Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy 44 (8) (2024)